Petri Dish: Non-viral vector startup launch; Foghorn’s new CFO

In this week’s Petri Dish we’ll take a look at a new Cambridge company founded by gene-editing experts that emerged with some big funding, as well as Foghorn Therapeutics’ new CFO and the awardees of $2.8 million in women's health funding.